IL6 and neoplasm: The activated STAT3 pathway, in response to the binding of IL-6 secreted to its glycoprotein 130 (GP130) receptor, promotes tumour progression through the induction of various target genes involved in tumour cell survival, proliferation, angiogenesis, metastasis, and cell adhesion.